Amrize Ltd $AMRZ Holdings Trimmed by Allspring Global Investments Holdings LLC

Key Points

• Allspring Global Investments cut its Amrize stake by 53.2% in the third quarter, selling 1.63 million shares and ending the period with 1.43 million shares valued at about $53.4 million.
• Other investors moved in the opposite direction, and Amrize insiders bought 34,155 shares worth roughly $1.46 million over the past three months, including purchases by the CEO and a director.
• Amrize met quarterly earnings expectations at $1.05 per share, while revenue rose 2.6% year over year to $3.77 billion. Analysts’ consensus rating is “Hold,” with an average price target of $47.65.

Allspring Global Investments Holdings LLC lowered its position in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 53.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,433,200 shares of the company's stock after selling 1,629,684 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.26% of Amrize worth $53,387,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in AMRZ. Pictet Asset Management Holding SA raised its holdings in Amrize by 4.3% in the third quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company's stock worth $230,110,000 after buying an additional 253,512 shares during the last quarter. CenterBook Partners LP lifted its position in shares of Amrize by 1,123.6% during the 3rd quarter. CenterBook Partners LP now owns 101,408 shares of the company's stock valued at $3,792,000 after buying an additional 93,120 shares in the last quarter. Kestra Advisory Services LLC lifted its holdings in Amrize by 12.7% during the third quarter. Kestra Advisory Services LLC now owns 165,401 shares of the company's stock valued at $6,184,000 after purchasing an additional 18,637 shares in the last quarter. Rakuten Investment Management Inc. bought a new position in Amrize in the 3rd quarter worth $1,220,000. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its stake in shares of Amrize by 8.8% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company's stock worth $78,985,000 after acquiring an additional 170,551 shares during the period.

Insiders Place Their Bets

In other news, Director Jacques Sanche acquired 4,150 shares of the business's stock in a transaction that occurred on Wednesday, August 26th. The stock was purchased at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the transaction, the director owned 9,766 shares in the company, valued at approximately $439,665.32. This trade represents a 73.90% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jan Jenisch acquired 26,000 shares of Amrize stock in a transaction that occurred on Wednesday, September 2nd. The stock was bought at an average price of $42.47 per share, for a total transaction of $1,104,220.00. Following the completion of the acquisition, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. This trade represents a 1.49% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 34,155 shares of company stock worth $1,461,276 in the last three months. 0.54% of the stock is currently owned by corporate insiders.

Amrize Trading Down 2.0%

Shares of AMRZ stock opened at $41.96 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The company has a market cap of $23.21 billion, a price-to-earnings ratio of 18.99, a PEG ratio of 1.68 and a beta of 0.04. Amrize Ltd has a 1-year low of $35.78 and a 1-year high of $65.94. The stock has a 50 day simple moving average of $39.46 and a 200-day simple moving average of $50.18.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts' consensus estimates of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The business had revenue of $3.77 billion during the quarter. During the same period in the prior year, the firm earned $0.98 EPS. The firm's revenue for the quarter was up 2.6% on a year-over-year basis. On average, equities research analysts expect that Amrize Ltd will post 2.30 EPS for the current fiscal year.

Amrize Announces Dividend

The business also recently announced a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be issued a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 10th. Amrize's payout ratio is currently 4.98%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on AMRZ shares. Oppenheimer reduced their price target on shares of Amrize from $55.00 to $52.00 and set an "outperform" rating on the stock in a report on Monday, November 2nd. Berenberg Bank lowered shares of Amrize from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $48.00 to $46.00 in a research report on Monday. Wall Street Zen lowered Amrize from a "hold" rating to a "sell" rating in a research note on Saturday. JPMorgan Chase & Co. lowered their price objective on shares of Amrize from $52.00 to $48.00 and set a "neutral" rating for the company in a research note on Tuesday, October 13th. Finally, Bank of America downgraded shares of Amrize from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $50.00 to $40.00 in a research report on Wednesday, September 2nd. Eight analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $47.65.

Amrize Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim's North American business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.